Literature DB >> 29492573

Normative Ranges of Transcranial Doppler Metrics.

Solventa Krakauskaite1, Corey Thibeault2, James LaVangie2, Mateo Scheidt2, Leo Martinez2, Danielle Seth-Hunter2, Amanda Wu2, Michael O'Brien2, Fabien Scalzo3, Seth J Wilk2, Robert B Hamilton4.   

Abstract

OBJECTIVE: To determine normal ranges for traditional transcranial Doppler (TCD) measurements for two age groups (14-19 and 20-29 years) and compare to existing literature results. The development of a normal range for TCD measurements will be required for the development of diagnostic and prognostic tests in the future.
MATERIALS AND METHODS: We performed TCD on the middle cerebral artery on 147 healthy subjects aged 18.9 years (SD = 2.1) and calculated mean cerebral blood flow velocity (mCBFV) and pulsatility index (PI). The study population was divided into two age populations (14-19 and 20-29 years).
RESULTS: There was a significant decrease in PI (p = 0.015) for the older age group with no difference in mCBFV.
CONCLUSION: Age-related, normal data are a prerequisite for TCD to continue to gain clinical acceptance. Our correlation of age-related TCD findings with previously published results as the generally accepted "gold standard" underlines the validity and sensitivity of this ultrasound method.

Entities:  

Keywords:  Pulsatility index; Transcranial Doppler; Traumatic brain injury; Ultrasound

Mesh:

Year:  2018        PMID: 29492573     DOI: 10.1007/978-3-319-65798-1_53

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  2 in total

1.  Functional transcranial Doppler: Selection of methods for statistical analysis and representation of changes in flow velocity.

Authors:  Stephan T Egger; Julio Bobes; Erich Seifritz; Stefan Vetter; Daniel Schuepbach
Journal:  Health Sci Rep       Date:  2021-10-06

2.  Effects of age, gender, and hemisphere on cerebrovascular hemodynamics in children and young adults: Developmental scores and machine learning classifiers.

Authors:  Marie Arsalidou; Nikolay Skuratov; Evgeny Khalezov; Alexander Bernstein; Evgeny Burnaev; Maxim Sharaev
Journal:  PLoS One       Date:  2022-02-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.